沃森生物(300142.SZ)擬使用3億元閒置募集資金用於暫時補充流動資金
格隆匯 1 月 6日丨沃森生物(300142.SZ)公佈,截止2020年12月31日,非公開發行股份購買資產並募集配套資金用於“上海澤潤研發項目”累計支出1.14億元,項目結項永久補充流動資金6613.95萬元;“沃森生物科技創新中心項目”累計支出7076.29萬元。尚未使用的募集資金餘額為3.51億元(含募集資金已收到的利息收入)。
為了滿足公司日常生產經營的需要,更好的發揮募集資金的使用效率,提升公司的盈利能力,公司擬使用“沃森生物科技創新中心項目”閒置募集資金4000萬元、已終止的募集資金投資項目閒置募集資金2.6億元,共計3億元用於暫時補充流動資金,使用期限自董事會審議批准實施之日起不超過12個月,到期將歸還至募集資金專户。
此次使用部分閒置募集資金暫時補充的流動資金主要用於公司及控股子公司主營業務相關的項目研發及生產經營使用,不會通過直接或間接的安排用於新股配售、申購,或用於股票及其衍生品種等高風險投資。此次閒置募集資金的使用不會影響“沃森生物科技創新中心項目”的正常進行。同時,公司擬使用3億元閒置募集資金用於暫時補充流動資金,按同期央行基準存貸款利差計算,12個月內可為公司減少利息支出約855萬元。因此,此次使用部分閒置募集資金暫時補充流動資金,有利於公司解決暫時的流動資金需求,提高募集資金使用效率,降低財務費用,提升公司經營效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.